Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Sees Significant Growth in Short Interest

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 41,500 shares, a growth of 229.4% from the February 29th total of 12,600 shares. Approximately 3.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 199,300 shares, the short-interest ratio is presently 0.2 days.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of CELZ. UBS Group AG acquired a new position in shares of Creative Medical Technology during the first quarter worth about $36,000. Citigroup Inc. bought a new position in Creative Medical Technology during the 1st quarter worth $47,000. Geode Capital Management LLC raised its position in Creative Medical Technology by 261.8% during the 1st quarter. Geode Capital Management LLC now owns 124,224 shares of the company’s stock worth $62,000 after purchasing an additional 89,886 shares during the last quarter. XTX Topco Ltd bought a new position in shares of Creative Medical Technology in the 1st quarter worth about $68,000. Finally, State Street Corp bought a new position in shares of Creative Medical Technology in the 1st quarter worth about $90,000. Institutional investors own 1.42% of the company’s stock.

Creative Medical Technology Stock Up 2.9 %

CELZ traded up $0.15 on Thursday, reaching $5.30. 3,098 shares of the company’s stock were exchanged, compared to its average volume of 211,318. The company’s 50 day moving average is $4.65 and its 200-day moving average is $4.67. Creative Medical Technology has a twelve month low of $3.93 and a twelve month high of $13.30.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc, a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility.